The evolving role of proteomics in the early detection of breast cancer

Timothy M. Pawlik, Henry M. Kuerer

Research output: Contribution to journalArticle

Abstract

There has been emerging interest in the examination of tumor protein expression (proteomics) as a means to identify novel diagnostic and therapeutic targets in women with breast cancer. Specifically, several investigators have examined biological fluids (serum and breast ductal fluid) and breast tissue in an attempt to detect novel proteomic profiles in women with breast carcinoma. The current tools of proteomic research are evolving, but include two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Initial studies have identified several unique biomarkers and proteomic profiles that were able to discriminate between non-cancer and breast cancer patients. In the future, the application of large-scale proteomic technology may provide a means of early detection, surveillance, and identification of potential therapeutic targets.

Original languageEnglish (US)
Pages (from-to)212-216
Number of pages5
JournalInternational Journal of Fertility and Women's Medicine
Volume50
Issue number5
StatePublished - 2005
Externally publishedYes

Fingerprint

Early Detection of Cancer
Proteomics
Breast Neoplasms
Breast
Electrophoresis, Gel, Two-Dimensional
Mass Spectrometry
Biomarkers
Research Personnel
Technology
Therapeutics
Serum
Research
Neoplasms
Proteins

Keywords

  • Electrophoresis (diagnostic)
  • Mass spectrometry (SELDI MS, SELDI TOF)

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

The evolving role of proteomics in the early detection of breast cancer. / Pawlik, Timothy M.; Kuerer, Henry M.

In: International Journal of Fertility and Women's Medicine, Vol. 50, No. 5, 2005, p. 212-216.

Research output: Contribution to journalArticle

@article{f72a243cd9084e00a85a578c59c96e53,
title = "The evolving role of proteomics in the early detection of breast cancer",
abstract = "There has been emerging interest in the examination of tumor protein expression (proteomics) as a means to identify novel diagnostic and therapeutic targets in women with breast cancer. Specifically, several investigators have examined biological fluids (serum and breast ductal fluid) and breast tissue in an attempt to detect novel proteomic profiles in women with breast carcinoma. The current tools of proteomic research are evolving, but include two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Initial studies have identified several unique biomarkers and proteomic profiles that were able to discriminate between non-cancer and breast cancer patients. In the future, the application of large-scale proteomic technology may provide a means of early detection, surveillance, and identification of potential therapeutic targets.",
keywords = "Electrophoresis (diagnostic), Mass spectrometry (SELDI MS, SELDI TOF)",
author = "Pawlik, {Timothy M.} and Kuerer, {Henry M.}",
year = "2005",
language = "English (US)",
volume = "50",
pages = "212--216",
journal = "International Journal of Fertility and Women's Medicine",
issn = "1534-892X",
publisher = "Medical Science Publishing International Inc.",
number = "5",

}

TY - JOUR

T1 - The evolving role of proteomics in the early detection of breast cancer

AU - Pawlik, Timothy M.

AU - Kuerer, Henry M.

PY - 2005

Y1 - 2005

N2 - There has been emerging interest in the examination of tumor protein expression (proteomics) as a means to identify novel diagnostic and therapeutic targets in women with breast cancer. Specifically, several investigators have examined biological fluids (serum and breast ductal fluid) and breast tissue in an attempt to detect novel proteomic profiles in women with breast carcinoma. The current tools of proteomic research are evolving, but include two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Initial studies have identified several unique biomarkers and proteomic profiles that were able to discriminate between non-cancer and breast cancer patients. In the future, the application of large-scale proteomic technology may provide a means of early detection, surveillance, and identification of potential therapeutic targets.

AB - There has been emerging interest in the examination of tumor protein expression (proteomics) as a means to identify novel diagnostic and therapeutic targets in women with breast cancer. Specifically, several investigators have examined biological fluids (serum and breast ductal fluid) and breast tissue in an attempt to detect novel proteomic profiles in women with breast carcinoma. The current tools of proteomic research are evolving, but include two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Initial studies have identified several unique biomarkers and proteomic profiles that were able to discriminate between non-cancer and breast cancer patients. In the future, the application of large-scale proteomic technology may provide a means of early detection, surveillance, and identification of potential therapeutic targets.

KW - Electrophoresis (diagnostic)

KW - Mass spectrometry (SELDI MS, SELDI TOF)

UR - http://www.scopus.com/inward/record.url?scp=33645453626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645453626&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 212

EP - 216

JO - International Journal of Fertility and Women's Medicine

JF - International Journal of Fertility and Women's Medicine

SN - 1534-892X

IS - 5

ER -